23 May 2013
Keywords: Paladin Labs, Immuron, Travelan, Travellers' diarrhea, Flu product candidate
Article | 30 November 2011
Melbourne, Australia-based Immuron (ASX: IMC) and Canada’s Paladin Labs (TSX: PLB) have signed a license and distribution deal ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 November 2011
29 November 2011
1 December 2011
© 2013 thepharmaletter.com